Metabolites, Volume 7, Issue 4 (December 2017) – 17 articles
Cover Story (view full-size image): Sepsis represents a severe immune dysregulation, secondary to systemic infection. The burden of sepsis is pronounced—the incidence is increasing and sepsis represents a leading cause of mortality internationally, particularly in the intensive care setting. The need for comprehensive and novel strategies for both assessing and treating sepsis are underlined by the lack of both sepsis-specific biomarkers and treatments. The endocannabinoid system (ECS) is an emerging area of research interest and is intrinsically linked to various key aspects of the immune function. As such, assessing potential biomarkers of the ECS may be a promising novel tool in the diagnosis and stratification of sepsis patients, as well as in guiding immunomodulatory therapies that target sepsis-induced immune dysregulation. View the paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.